GDRX GoodRx: Enterprise Value-to-Revenue Multiple

Public company logo of GoodRx (GDRX)

Limited pricing power due to dependence on pharmacy chains is constraining margins for GoodRx Holdings, Inc. (GDRX), as evidenced by the enterprise value-to-annual revenue multiple, where the metric stands at 1621.31. The trend is driven by the number of paid subscribers and PBM commissions. Stability is underpinned by user habits of searching for coupons, ensuring regular fees from every drug sale.

goodrx.com (GDRX) - EV/Sales Multiple from 11/23/2025 to 11/20/2026

GDRX (GoodRx Holdings, Inc.): analytical breakdowns and indicator data

- current price and projected stock value:
- company stock capitalization data:
- money and cash flow information:
Fundamental company valuation:GDRX goodrx.com
Original product of GoodRx Gold

This indicator determines the total enterprise value relative to sales volume, excluding the impact of debt load. The metric is calculated as the ratio of total capitalization to revenue, making it sensitive to revenue growth rates. The current enterprise value-to-revenue multiple is 1621.31. This chart's price action signals that the asset is overbought when expansion slows. For GoodRx Holdings, Inc. (GDRX), this figure reflects the monetization efficiency of the coupon aggregator amid limited pricing power over pharmacy chains.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|Schrodinger Corp - EV/Sales Multiple|Enterprise Value to Sales Volume PHR|OMDA: EV/Sales Multiple|Evolent Health, Inc. - Business Value to Revenue|Enterprise Value-to-Revenue Ratio HealthStream Corp|DH: Business Value to Revenue|Company Value to Revenue CCSI (Consensus)|Total Company Value-to-Revenue Ratio Agilon Health|EV/Sales Multiple ABSI (Absci)|soyoung.com (SY) - Enterprise Value-to-Revenue Multiple|NRC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Spok Holdings Inc SPOK|OPRX (OptimizeRx) - Company Value to Revenue|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)